This content is machine translated TREATswitzerland Register Evaluation of system therapies for AD In addition to conventional immunosuppressants, several monoclonal antibodies (biologics) and Janus kinase inhibitors (JAK-i) are now approved for the systemic treatment of atopic dermatitis (AD) in Switzerland. The primary objective...…
View Post 3 min This content is machine translated Case report: Hiccups after ketoacidosis Nebulized lidocaine brings relief Persistent hiccups are a rare but distressing symptom that can significantly affect the quality of life of patients with diabetic ketoacidosis (DKA). In one clinical case, treatment with inhaled nebulized...…
View Post 8 min This content is machine translated Cardiogenic shock - 2025 update Between standardization, team processes and targeted cycle support Cardiogenic shock (CS) is and remains the most dramatic form of acute circulatory failure in cardiology. Despite decades of intensive research, hospital mortality has long remained in the range of...…
View Post 10 min This content is machine translated Collagenoses Scleroderma – Current recommendations for diagnosis and therapy 2025 Early detection is critical for treatment options of this multisystem disease with cutaneous involvement. Raynaud’s attacks are often in early stages and should always be further evaluated. Advances in research...… CME-Test
View Post 5 min This content is machine translated Multiple sclerosis Avoiding the nocebo trap with natalizumab biosimilars Monoclonal antibodies such as natalizumab are indispensable for multiple sclerosis therapy. A first recently approved biosimilar is clinically equivalent, as studies have shown. Nevertheless, reservations are widespread in practice. Patients...…
View Post 3 min This content is machine translated SGLT2 inhibitors and glucocorticoids Protective effect on kidney function is maintained SGLT2 inhibitors have been shown in randomized trials to be effective in improving cardiovascular and renal outcomes. However, the populations in these studies were carefully selected, usually excluding patients under...…
View Post 6 min This content is machine translated COPD and comorbidities Exacerbation frequency is associated with cardiopulmonary disease burden Exacerbation severity and frequency are crucial for the prognosis of COPD, but also appear to have a major impact on the course of comorbidities. There is a growing body of...…
View Post 12 min This content is machine translated Multiple myeloma DREAMM-8: Key study in the development of BCMA therapy up to DREAMM-14 The DREAMM-8 data presented at this year’s ASCO provided robust evidence of the efficacy and tolerability of the BPd combination (belantamab mafodotin, pomalidomide and dexamethasone) for the treatment of recurrent...…
View Post 9 min This content is machine translated Catheter ablation for atrial fibrillation 2025 Pulsed field versus radio frequency – where do we stand? In the treatment of atrial fibrillation (AF), catheter ablation has developed from a specialized option to the mainstay of a modern rhythm strategy within a decade. In 2025, two developments...…
View Post 5 min This content is machine translated Antithymocyte globulin in children with T1D Old medicine, new hope The well-known immunomodulatory drug antithymocyte globulin (ATG) can effectively inhibit the progression of type 1 diabetes (T1D) in young patients at low doses, while at the same time having a...…
View Post 8 min This content is machine translated Atopic dermatitis From skin barrier disorder to atopic march? An early onset and persistent course of atopic dermatitis are the strongest predictors of atopic march. New diagnostic methods such as electrical impedance spectroscopy and the analysis of biomarkers from...…
